These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20439246)

  • 1. Pathophysiologic mechanisms linking adipose tissue and cardiometabolic risk.
    Allende-Vigo MZ
    Endocr Pract; 2010; 16(4):692-8. PubMed ID: 20439246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipocytes and cardiometabolic risk.
    Allende-Vigo MZ
    Am J Ther; 2012 Jul; 19(4):294-9. PubMed ID: 21150766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose tissue, inflammation and atherosclerosis.
    Gustafson B
    J Atheroscler Thromb; 2010 Apr; 17(4):332-41. PubMed ID: 20124732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation.
    Lechner K; McKenzie AL; Kränkel N; Von Schacky C; Worm N; Nixdorff U; Lechner B; Scherr J; Weingärtner O; Krauss RM
    Metab Syndr Relat Disord; 2020 May; 18(4):176-185. PubMed ID: 32119801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adipose tissue: a multifunctional organ].
    Bon GB
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):23S-28S. PubMed ID: 18773748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association.
    Bays HE; Toth PP; Kris-Etherton PM; Abate N; Aronne LJ; Brown WV; Gonzalez-Campoy JM; Jones SR; Kumar R; La Forge R; Samuel VT
    J Clin Lipidol; 2013; 7(4):304-83. PubMed ID: 23890517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipose Tissue in Metabolic Syndrome: Onset and Progression of Atherosclerosis.
    Luna-Luna M; Medina-Urrutia A; Vargas-Alarcón G; Coss-Rovirosa F; Vargas-Barrón J; Pérez-Méndez Ó
    Arch Med Res; 2015 Jul; 46(5):392-407. PubMed ID: 26009250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clusterin and Its Role in Insulin Resistance and the Cardiometabolic Syndrome.
    Wittwer J; Bradley D
    Front Immunol; 2021; 12():612496. PubMed ID: 33717095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overweight and obesity: the pathogenesis of cardiometabolic risk.
    Bray GA; Clearfield MB; Fintel DJ; Nelinson DS
    Clin Cornerstone; 2009; 9(4):30-40; discussion 41-2. PubMed ID: 19789062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Different Adipose Depots on Cardiovascular Disease.
    Diaz-Canestro C; Xu A
    J Cardiovasc Pharmacol; 2021 Dec; 78(Suppl 6):S30-S39. PubMed ID: 34840259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update.
    Piché ME; Poirier P; Lemieux I; Després JP
    Prog Cardiovasc Dis; 2018; 61(2):103-113. PubMed ID: 29964067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
    Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epicardial, pericardial and total cardiac fat and cardiovascular disease in type 2 diabetic patients with elevated urinary albumin excretion rate.
    Christensen RH; von Scholten BJ; Hansen CS; Heywood SE; Rosenmeier JB; Andersen UB; Hovind P; Reinhard H; Parving HH; Pedersen BK; Jørgensen ME; Jacobsen PK; Rossing P
    Eur J Prev Cardiol; 2017 Sep; 24(14):1517-1524. PubMed ID: 28650207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial and Perivascular Adipose Tissue Abnormalities in Obesity-Related Vascular Dysfunction: Novel Targets for Treatment.
    Schinzari F; Tesauro M; Cardillo C
    J Cardiovasc Pharmacol; 2017 Jun; 69(6):360-368. PubMed ID: 28141700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular Mechanisms Driving Sex Differences in Adipose Tissue Biology and Body Shape in Humans and Mouse Models.
    Karastergiou K; Fried SK
    Adv Exp Med Biol; 2017; 1043():29-51. PubMed ID: 29224089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic obesity: the paradox between visceral and subcutaneous fat.
    Hamdy O; Porramatikul S; Al-Ozairi E
    Curr Diabetes Rev; 2006 Nov; 2(4):367-73. PubMed ID: 18220642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fat and Cardiometabolic Risk Burden.
    Purnamasari D
    Acta Med Indones; 2017 Apr; 49(2):89-90. PubMed ID: 28790221
    [No Abstract]   [Full Text] [Related]  

  • 19. Epicardial adipose tissue and idiopathic deep venous thrombosis: an association study.
    Mazzoccoli G; Copetti M; Dagostino MP; Grilli M; Fontana A; Pellegrini F; Greco A
    Atherosclerosis; 2012 Aug; 223(2):378-83. PubMed ID: 22748278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipocyte size as a determinant of metabolic disease and adipose tissue dysfunction.
    Laforest S; Labrecque J; Michaud A; Cianflone K; Tchernof A
    Crit Rev Clin Lab Sci; 2015; 52(6):301-13. PubMed ID: 26292076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.